Regarding laboratory studies, recent immunohistochemical studies have suggested the use of single antibodies such as ki‐ 67, Ber‐EP4, CD34,CK 20, Bcl2 and AR to differentiate BCC from BFH. The gene discussed is BCL2; the disease is skin basal cell carcinoma.